Results 241 to 250 of about 354,007 (274)
Some of the next articles are maybe not open access.

Pharmacology of leukotriene receptor antagonists

American journal of respiratory and critical care medicine
Preclinical pharmacological studies have demonstrated that cysLT1 receptor antagonists, such as zafirlukast, montelukast, and pobilukast, are potent and selective antagonists of cysteinyl leukotriene (cysLT) activity. In vitro, these agents compete with [3H]LTD4 for binding to cysLT1 receptors present on guinea pig and human lung cell membranes.
openaire   +1 more source

Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.

Allergy and Asthma Proceedings, 2010
J. Tamaoki   +7 more
semanticscholar   +1 more source

The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C in the guinea-pig ileum

European Journal of Pharmacology, 1996
Eva Wikström Jonsson   +2 more
exaly  

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist

Journal of Allergy and Clinical Immunology, 1998
T F Reiss, Theodore F Reiss, L C Altman
exaly  

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

Clinical and Experimental Allergy, 2001
W. Storms   +7 more
semanticscholar   +1 more source

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis.

American Journal of Respiratory and Critical Care Medicine, 1999
T. Pullerits   +4 more
semanticscholar   +1 more source

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

Archives of Internal Medicine, 2000
A. Reicin   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy